Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | BCHE | P06276 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | CDC25B | P30305 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | RAB9A | P51151 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | MAOA | P21397 | 3/20 | 0.48 |
| ▸ | S100A4 | P26447 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | APAF1 | O14727 | 2/20 | 0.48 |
| ▸ | TDP2 | O95551 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14003716 | 0.82 | CDC25B (0.73) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL1670775 | 0.80 | CES1 (0.62) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL11290381 | 0.78 | CES1 (0.60) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL11293121 | 0.78 | CES1 (0.60) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL11287850 | 0.78 | CES1 (0.60) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL88188 | 0.73 | CES1 (0.52) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL29353628 | 0.73 | CES1 (0.52) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL3498908 | 0.73 | MEN1 (0.52) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL29411070 | 0.73 | MEN1 (0.52) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL8909389 | 0.71 | MEN1 (0.50) | CES1BCHEMEN1KMT2ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2207750-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC Technology, INC. (US) | 2010-07-21 | — | — | EP | disclosed |
| US-7696377-B2 | Stabilizer and method for stabilizing hydroxylamine, and stabilized hydroxylamine solution | SHOWA DENKO K.K. (JP) | 2010-04-13 | — | — | US | disclosed |
| WO-2009058273-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
| US-7491846-B2 | Process for producing hydroxylamine | SHOWA DENKO K.K. (JP) | 2009-02-17 | — | — | US | disclosed |
| US-20090043125-A1 | STABILIZER AND METHOD FOR STABILIZING HYDROXYLAMINE, AND STABILIZED HYDROXYLAMINE SOLUTION | SHOWA DENKO K.K. (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20080193362-A1 | Process for Producing Hydroxylamine | SHOWA DENKO K.K. (JP) | 2008-08-14 | — | — | US | disclosed |
| WO-2007049663-A1 | STABILIZER AND METHOD FOR STABILIZING HYDROXYLAMINE, AND STABILIZED HYDROXYLAMINE SOLUTION | SHOWA DENKO K.K. (JP) | 2007-05-03 | — | — | WO | disclosed |
| WO-2006062178-A2 | STABILIZER FOR HYDROXYLAMINE, METHOD FOR STABILIZING HYDROXYLAMINE, AND STABILIZED HYDROXYLAMINE SOLUTION | SHOWA DENKO K.K. (JP) | 2006-06-15 | — | — | WO | disclosed |
| EP-1663862-A2 | PROCESS FOR PRODUCING HYDROXYLAMINE | Showa Denko K.K. (JP) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005016817-A2 | PROCESS FOR PRODUCING HYDROXYLAMINE | SHOWA DENKO K. K. (JP) | 2005-02-24 | — | — | WO | disclosed |
| EP-0103381-B1 | SUBSTITUTED ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONES | WARNER-LAMBERT COMPANY (US) | 1987-09-23 | — | — | EP | disclosed |
| EP-0147639-A2 | Stabilized solutions of hydroxyl amine or salts thereof | BASF Aktiengesellschaft (DE) | 1985-07-10 | — | — | EP | disclosed |
| EP-0081777-A2 | Process to produce vinyl chloride polymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | HNMT, HMOX2, EGLN2 | CES1 2161/4885BCHE 1118/4885MEN1 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.